Previous close | 0.3500 |
Open | 0.3500 |
Bid | 0.0000 |
Ask | 4.5000 |
Strike | 55.00 |
Expiry date | 2025-01-17 |
Day's range | 0.3500 - 0.3500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny
In this piece, we will take a look at the fastest declining large city in the US. If you’re interested in knowing which other large cities in the US are witnessing a population decline (and whether big hitters like New York City also made the cut), you can check out 15 Fastest Declining Large Cities […]
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded through available cash balances. Shares may be repurchased through open market repurchases, including